Here is a good article related to MDCN Medican Enterprises Inc

New Post Public Reply Private Reply Replies (0) Message Board
StockAwareness
Here is a good article related to MDCN Medican Enterprises Inc

Coltyn Turner has Crohn’s disease. At 15 years old and facing a diseased colon, Turner succinctly demonstrates the effect of his cannabis treatment. With touching sincerity and undeniable resiliency, these 30 seconds will move you with watery eyes to a cry for legalization.

It’s painful to think about the number of kids in Coltyn’s situation without safe access, but you can bet that’s nothing compared to the pain those children face.

Watch and share to help the push towards the legalization of cannabis.

PSA from Coltyn Turner about Cannabis and Crohn's Disease

Last week, the U.S. House of Representatives took part in a “marijuana vote-a-rama” of sorts, with several amendments to dealing with marijuana to be offered on the floor during the FY2016 Commerce, Justice, and Science Appropriations Bill. The amendments offered will cover topics from hemp and cannabidiol (CBD) to protection of state adult-use laws. Not to be lost in the shuffle is the vote to reauthorize the Rohrabacher-Farr Amendment, which stipulates that the Department of Justice is not to spend any funds inferring with lawful state medical marijuana conduct. Patients, such as 15-year old Crohn’s patient/Colorado refugee Coltyn Turner, need the protection that a reauthorized Rohrabacher-Farr Amendment would continue to offer.

The amendment was originally passed the House in May 2014, 219-189, with a strong bipartisan showing of 49 Republicans joining 170 Democrats. Later in December, Senator Mikulski helped ensure the bill remained in the final CRomnibus bill that President Obama signed into law. While its passage marked the first time since Congress approved a medical marijuana reform since designating marijuana in Schedule I of the Controlled Substances Act, momentum for additional medical marijuana reforms grown substantially in the past 12 months with introduction of the CARERS Act in both chambers and the passage of the Veterans Equal Access Amendment offered by Senators Daines (R-MT) and Merkley (D-OR) in Senate Appropriations Committee last month.

Once again the amendment showing strong bipartisan support out of the gate, with 6 Republican, and 6 Democrat cosponsors lending their name to this year’s version: Rohrabacher (R-CA), Farr (D-CA), Ribble (R-WI), Lee (D-CA), Massie (R-KY), Blumenauer (D-OR), Heck (R-NV), Cohen (D-TN), Young (R-AK) Polis (D-CO), McClintock (R-CA), Titus (D-NV). The number of states listed on the amendment has jumped from 32 to 39, with New York, North Carolina,Virginia, Georgia,Oklahoma,Texas, and Louisiana becoming the latest states to be added to the list. This now means that about 85% of the U.S. population now lives somewhere with some sort of medical marijuana patient protection. Patients like Coltyn cannot afford to wait for the federal government to play catch-up and be denied access to their medicine, and in fact, they won’t wait, as Coltyn has said,“I’d rather be illegally alive than legally dead.” With an estimated 2.4 million medical marijuana patients as of October 2014 who are being “illegally healed” in the eyes of the Department of Justice who makes no internal distinction between medical and non-medical marijuana use, the protections afforded by the Rohrabacher-Farr Amendment are needed now more than ever.

During the floor debate last year, many of the amendment cosponsors spoke in favor of the amendment, thereby establishing the legislative intent of the amendment. From their words as well as the words of the amendment’s opponents, it was clear that the intent of the amendment was to prevent the Dept. of Justice from interfering with with state legal medical marijuana conduct. As Rep. Farr put it:

“This is essentially saying, look, if you are following State law, you are a legal resident doing your business under State law, the Feds just can’t come in and bust you and bust the doctors and bust the patient. It is more than half the States. So you don’t have to have any opinion about the value of marijuana. This doesn’t change any laws. This doesn’t affect one law, just lists the States that have already legalized it only for medical purposes, only medical purposes, and says, Federal Government, in those States, in those places, you can’t bust people. It seems to me a practical, reasonable amendment in this time and age.”

In practical terms, it is still hard to measure the true effectiveness of the amendment, but there has been an appreciable decrease in the amount of federal interference with state-legal medical marijuana conduct. This is not to say that DOJ is being in full compliance or is even being transparent about how it has been complying with the spending restriction. While DEA raids of state-legal facilities are no longer the regular occurrence they once were, raids and their subsequent prosecutions are still continuing, even in the absence of proof that state laws were being violated, such as the Kettle Falls Five case in Washington State. While Reps. Rohrabacher and Farr have sought answers from DOJ on why this kind of interference is continuing to take place, the Department has largely sidestepped the issue, offering a terse quasi-explanation in the L.A. Times, but little else. But as Rep. Farr responded in a tweet, “@TheJusticeDept lawyers can try to parse words but Congress was clear: Stop wasting funds/resources prosecuting patients!”

We couldn’t say it better ourselves, but it’s worth repeating, it is a waste of taxpayer funds to prosecute state-legal medical marijuana patients. To further reiterate Rep. Farr, passage of the amendment sends a strong signal to DOJ that interfering with lawful state medical marijuana conduct goes against the sense of Congress. This sense is shared by over 85% of Americans who believe that patients should have safe and legal access to medical marijuana programs under the recommendation of a physician. The health of patients like Coltyn depends on the federal government not interfering with state medical marijuana laws (his self-produced PSA underscores the reason why it’s important). Supporting this medical marijuana amendment is not only compassionate, but also fiscally pragmatic and politically safe. This vote should be a no-brainer for conservatives and liberals alike who want to keep big government out of the doctor’s office. Take action and ask your U.S. Representative to VOTE AYE on the Rohrabacher-Farr Amendment.

http://greenrushinvestors.com/legalization-of-cannabis/

Medican Enterprises Inc (MDCN) Stock Research Links

MDCN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 261

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 255

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 176

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 211

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 102

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 199

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 99

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 374

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Crédit Agricole Assurances Reports Remarkable Growth in 2024

Updated Category News Views 81

Crédit Agricole Assurances Reports Remarkable Growth in 2024 Crédit Agricole Assurances recently revealed their impressive performance for the first nine months of 2024, showcasing an 18.2% increase in total revenue, amounting to €32.8 billion. This significant growth reflects the company's dedication to its clients and the effectiveness of its diverse insurance...

Continue Reading
Enerpac Tool Group's Earnings Preview and Stock Insights

Updated Category News Views 72

Enerpac Tool Group's Upcoming Earnings Announcement Enerpac Tool Group (NYSE: EPAC) is set to release its quarterly earnings report shortly. This announcement is pivotal for both current investors and those considering an investment in the company. With analysts predicting an earnings per share (EPS) of $0.53, excitement is building around whether Enerpac will meet or...

Continue Reading
Unlocking Sales Potential: The Power of Unified Measurement

Updated Category News Views 163

Unlocking Sales Potential: The Power of Unified Measurement Marketing teams are faced with the challenge of demonstrating their impact amidst shifting sales channels. With the rise of platforms like Amazon, TikTok Shop, and other marketplaces, traditional measurement tools have fallen short, often focusing solely on .com sales. This shortfall can lead to up to 42% of...

Continue Reading
Rigel Pharmaceuticals Prepares for 2024 Financial Results Call

Updated Category News Views 81

Rigel Pharmaceuticals to Announce Fourth Quarter Results Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has made an important announcement detailing its plans to share its financial performance for the fourth quarter and the full year of 2024. This financial disclosure is scheduled to occur after the market closes on a day soon approaching in March. Details on the Conference...

Continue Reading
DENSO Partners for Michigan Workforce Development Initiatives

Updated Category News Views 213

DENSO Collaborates to Enhance Michigan's Workforce DENSO, a prominent mobility supplier, is making significant strides in workforce development by partnering with local businesses and organizations in Michigan. This collaboration has successfully secured over $550,000 in workforce training grants aimed at supporting leadership and skilled trades upskilling in the region....

Continue Reading